Tenet Board Adds Two New Independent Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Adobe CFO Dan Durn to depart company in June 2026
- Alibaba falls on China AI capex report; Citi says selloff is premature
UBS Reiterates Buy on Tenet Healthcare (THC) After Hosting Management Meetings
January 21, 2016 11:23 AM ESTUBS maintained a Buy rating on Tenet Healthcare (NYSE: THC), and cut the price target to $51.00 (from $62.00), after meeting with management. THC reiterated that it expects to show solid growth in 2016 relative to its pro-forma 2015 EBITDA run rate of $2.3 bln. Consensus expectations call for just under $2.5... More
Mizuho Securities Upgrades Tenet Healthcare (THC) to Outperform
January 19, 2016 8:48 AM ESTMizuho Securities upgraded Tenet Healthcare (NYSE: THC) from Neutral to Outperform with a price target of $30.00 as two Glenview partners join the board.
Analyst Sheryl R. Skolnick commented, "Glenview's two HC partners are joining THC's Board and the firm can also appoint... More
